SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-20-012500
Filing Date
2020-03-24
Accepted
2020-03-24 16:05:27
Documents
75
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K scph-10k_20191231.htm 10-K 2158325
2 EX-4.2 scph-ex42_185.htm EX-4.2 33971
3 EX-10.9 scph-ex109_186.htm EX-10.9 78042
4 EX-21.1 scph-ex211_184.htm EX-21.1 4082
5 EX-23.1 scph-ex231_7.htm EX-23.1 3614
6 EX-31.1 scph-ex311_9.htm EX-31.1 18281
7 EX-32.1 scph-ex321_10.htm EX-32.1 9863
8 GRAPHIC g4gnnpjcte2t000001.jpg GRAPHIC 31901
  Complete submission text file 0001564590-20-012500.txt   7161839

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT scph-20191231.xml EX-101.INS 1340520
10 XBRL TAXONOMY EXTENSION SCHEMA scph-20191231.xsd EX-101.SCH 53606
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE scph-20191231_cal.xml EX-101.CAL 57511
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE scph-20191231_def.xml EX-101.DEF 162624
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE scph-20191231_lab.xml EX-101.LAB 442575
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE scph-20191231_pre.xml EX-101.PRE 336312
Mailing Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803
Business Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Filer) CIK: 0001604950 (see all company filings)

IRS No.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38293 | Film No.: 20738413
SIC: 2834 Pharmaceutical Preparations